TL;DR: Aetna, a CVS Health company, modified CPB 0468 governing magnesium sulfate and terbutaline pump therapy for preterm labor, effective September 26, 2025. If your team bills J3475, J3105, S9208, S9349, or the home infusion pump codes E0779–E0781 for Aetna patients, this coverage policy update affects your claims.
The change narrows the covered use of magnesium sulfate injections (J3475) to short-term pregnancy prolongation — up to 48 hours — for patients at risk of preterm delivery within seven days. Billing teams managing obstetric or high-risk pregnancy cases should audit their charge capture and documentation protocols before submitting claims against ICD-10 codes O60.2 and O60.3.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Magnesium Sulfate and Terbutaline Pump for Preterm Labor |
| Policy Code | CPB 0468 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | Obstetrics, Maternal-Fetal Medicine, Home Infusion, DME Suppliers |
| Key Action | Confirm all J3475 claims document short-term use (≤48 hours) with delivery risk within seven days before billing |
Aetna Magnesium Sulfate Coverage Criteria and Medical Necessity Requirements 2025
The Aetna magnesium sulfate coverage policy under CPB 0468 Aetna system ties medical necessity to a specific clinical window. Aetna covers magnesium sulfate injections billed under J3475 only when the goal is short-term prolongation of pregnancy — up to 48 hours — and the patient faces a genuine risk of preterm delivery within seven days.
That's a tight clinical box. "Short-term" isn't just a descriptor here — it's a coverage limit. If your documentation doesn't specify the 48-hour intent and the seven-day delivery risk, Aetna has grounds for a claim denial. Make sure your clinical notes, discharge summaries, and billing records use that exact language.
The ICD-10 diagnosis codes that support this coverage are O60.2 (preterm labor without delivery, after 22 weeks but before 37 weeks) and O60.3 (same characterization). Both must be appropriately documented to support medical necessity. Don't assume a preterm labor diagnosis alone is enough — the timing criteria matter.
For home infusion settings, CPT 99601 covers the visit up to two hours. Add-on code 99602 covers each additional hour. Home infusion therapy for tocolytic therapy is also reported under S9349 and the home management code S9208. Prior authorization is almost certainly required for home-based therapy under this policy — verify this with Aetna before any home infusion service starts.
The durable medical equipment codes E0779, E0780, and E0781 cover the ambulatory infusion pumps used to deliver this therapy. E0779 is for mechanical, reusable pumps running eight hours or longer. E0780 covers the same pump type for infusions under eight hours. E0781 covers single or multi-channel electric or battery-operated pumps with administration sets. For DME suppliers billing these codes, the medical necessity documentation burden is real — Aetna will want evidence that the clinical criteria are met before reimbursement.
Aetna Terbutaline Pump and Magnesium Sulfate Exclusions and Non-Covered Indications
CPB 0468 has a notable history here, and it matters for billing teams. Terbutaline sulfate (J3105) appears in the covered code set, but its coverage is conditional. The FDA issued a safety warning against the use of terbutaline for prolonged tocolysis — specifically subcutaneous pump delivery beyond 48–72 hours or in outpatient settings. Aetna's policy reflects that concern.
The real issue is that terbutaline pump therapy for maintenance tocolysis — meaning ongoing outpatient use beyond the acute window — is not supported under this coverage policy. If your providers are using terbutaline pumps for long-term outpatient tocolysis and billing J3105 with S9349 or E0781, those claims are high-risk. Aetna considers that use experimental or not medically necessary under this policy.
The codes S9208 and S9349 are technically in the covered set, but they carry the same condition: selection criteria must be met. For home management of preterm labor under S9208 and home infusion tocolytic therapy under S9349, the clinical situation must still fit the acute, short-term window — not ongoing maintenance. If you're billing these codes for patients receiving weeks of home tocolytic therapy, stop and review the documentation trail before the next claim goes out.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Short-term magnesium sulfate for pregnancy prolongation (up to 48 hours) | Covered | J3475, O60.2, O60.3 | Delivery risk within 7 days must be documented |
| Home infusion visit for tocolytic therapy | Covered (criteria apply) | 99601, 99602, S9349 | Prior authorization likely required |
| Home management of preterm labor | Covered (criteria apply) | S9208, O60.2, O60.3 | Administrative and pharmacy services included under code |
| Ambulatory infusion pump — mechanical, ≥8 hours | Covered (criteria apply) | E0779 | DME; medical necessity documentation required |
| Ambulatory infusion pump — mechanical, <8 hours | Covered (criteria apply) | E0780 | DME; medical necessity documentation required |
| Ambulatory infusion pump — electric/battery operated | Covered (criteria apply) | E0781 | DME; confirm pump type matches billing code |
| Terbutaline injection, acute use | Covered (criteria apply) | J3105 | FDA safety concerns limit scope; short-term acute use only |
| Long-term outpatient terbutaline pump therapy | Not Covered / Experimental | J3105, E0779–E0781 | FDA warning against prolonged tocolysis; Aetna does not support ongoing maintenance use |
Aetna Preterm Labor Billing Guidelines and Action Items 2025
This is where the rubber meets the road. The effective date is September 26, 2025 — if your billing team hasn't reviewed open claims and upcoming authorizations against this updated policy, start now.
| # | Action Item |
|---|---|
| 1 | Audit all open J3475 claims before billing. Confirm that each claim documents the 48-hour treatment window and the seven-day preterm delivery risk. Any claim missing those specifics is a denial waiting to happen. Pull your charge capture workflow and add a documentation checkpoint for these two criteria. |
| 2 | Review your J3105 billing immediately. Terbutaline sulfate reimbursement under this policy applies only to acute, short-term use. If your team has been billing J3105 with home infusion codes like S9349 or S9208 for ongoing outpatient tocolysis, that's a problem. Pull those claims, review the documentation, and talk to your compliance officer before submitting anything further. |
| 3 | Verify prior authorization on all home infusion cases. Home tocolytic therapy under S9208 and S9349 almost always requires prior auth with Aetna. Confirm the authorization is in place before the service — not after. A missed prior authorization on a home infusion case is a full denial, and these claims carry significant dollar value. |
| 4 | Match pump codes to actual equipment. DME billing for E0779, E0780, and E0781 needs to reflect the actual pump in use. E0779 is for mechanical reusable pumps running eight hours or more. E0780 is the same type for under eight hours. E0781 is for electric or battery-operated pumps. A mismatch between the pump type and the billed HCPCS code is a straightforward claim denial — and an audit flag. |
| 5 | Update your ICD-10 documentation workflow. Both O60.2 and O60.3 are covered under this policy. Make sure coders know which applies to each case. O60.2 and O60.3 both describe preterm labor without delivery between 22 and 37 weeks, but the specifics of each patient's clinical picture determine the right code. Sloppy ICD-10 selection on these claims invites additional scrutiny. |
| 6 | Train your billing team on the clinical criteria. This isn't just a coder issue — it's a charge capture and documentation issue that starts at the clinical level. If your providers aren't documenting the seven-day delivery risk and the short-term treatment intent, no amount of billing cleanup will save those claims. Loop in your medical director or a billing consultant if the clinical documentation protocols need an overhaul. |
If your practice has a high volume of high-risk obstetric cases billed to Aetna, talk to your compliance officer about a targeted review of preterm labor claims from the past 12 months. This policy change suggests Aetna is tightening its position on tocolytic therapy — and retroactive denials on previously submitted claims are possible if prior claims don't align with the updated criteria.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Preterm Labor Tocolytic Therapy Under CPB 0468
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 99601 | CPT | Home infusion/specialty drug administration, per visit (up to 2 hours) |
| 99602 | CPT | Each additional hour (add-on to 99601) |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| E0779 | HCPCS | Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater |
| E0780 | HCPCS | Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours |
| E0781 | HCPCS | Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administration sets |
| J3105 | HCPCS | Injection, terbutaline sulfate, up to 1 mg |
| J3475 | HCPCS | Injection, magnesium sulfate, per 500 mg |
| S9208 | HCPCS | Home management of preterm labor, including administrative services, professional pharmacy services |
| S9349 | HCPCS | Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| O60.2 | Preterm labor without delivery (after 22 weeks but before 37 weeks) |
| O60.3 | Preterm labor without delivery (after 22 weeks but before 37 weeks) |
Get the Full Picture for CPT 99601
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.